We're proud to announce the launch of our enhanced bioanalytical service offering—built to deliver the dependable, regulatory-ready data your program needs, faster than ever before.
Eurofins Viracor BioPharma provides comprehensive bioanalytical testing services to support R&D and early-stage drug development programs. Our experienced scientific team partners with biotech and pharmaceutical innovators to deliver high-quality bioanalysis for large molecule programs. From assay development and method validation to sample analysis and data reporting, our laboratories provide the expertise and regulatory rigor needed to move from your program forward with confidence.
Flexible Bioanalytical Support for Drug Discovery and Development
Whether you need bioanalytical method development, PK analysis, biomarker testing, or regulated bioanalytical services, our team works as an extension of your research organization. Using advanced analytical platforms including flow cytometry and ligand-binding assays, we deliver reliable, reproducible results that support critical decision-making across preclinical and clinical studies.
Complete the short form below to take advantage of limited-time promotional pricing.
Promotion Terms and Conditions
This promotion applies to anti‑drug antibody (ADA) assays, pharmacokinetic (PK) assays, and polymerase chain reaction (PCR) assays offered by Eurofins Viracor BioPharma Services. The promotion excludes reagent costs and current Eurofins Pharma Bioanalytical Services opportunities and cannot be combined with any other discounts. Eligible proposals must be created by May 1, 2026 and the associated statement of work (SOW) must be signed by June 30, 2026 with a total project value exceeding $100,000. Eurofins reserves the right to modify, extend, or terminate this promotion at any time without prior notice.